Can-Fite BioPharma (CANF) Reports $3.2M Registered Direct Offering

April 2, 2019 9:02 AM EDT Send to a Friend
Can-Fite BioPharma Ltd. (NYSE: CANF) today announced that it has entered into a definitive agreement with certain institutional investors to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login